85 related articles for article (PubMed ID: 8328738)
1. Renal mechanism of trimethoprim-induced hyperkalemia.
Velázquez H; Perazella MA; Wright FS; Ellison DH
Ann Intern Med; 1993 Aug; 119(4):296-301. PubMed ID: 8328738
[TBL] [Abstract][Full Text] [Related]
2. Renal potassium handling in carriers of the Gly40Ser mutation of the glucagon receptor suggests a role for glucagon in potassium homeostasis.
Bankir L; Barbato A; Russo O; Crambert G; Iacone R; Bouby N; Perna L; Strazzullo P
Physiol Rep; 2018 Apr; 6(8):e13661. PubMed ID: 29671960
[TBL] [Abstract][Full Text] [Related]
3. Serum Sodium and Potassium Distribution and Characteristics in the US Population, National Health and Nutrition Examination Survey 2009-2016.
Overwyk KJ; Pfeiffer CM; Storandt RJ; Zhao L; Zhang Z; Campbell NRC; Wiltz JL; Merritt RK; Cogswell ME
J Appl Lab Med; 2021 Jan; 6(1):63-78. PubMed ID: 33236098
[TBL] [Abstract][Full Text] [Related]
4. A New Understanding of Potassium's Influence Upon Human Health and Renal Physiology.
McCormick JA; Topf J; Tomacruz ID; Grimm PR
Adv Kidney Dis Health; 2023 Mar; 30(2):137-147. PubMed ID: 36868729
[TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose.
Perazella MA; Mahnensmith RL
Clin Nephrol; 1996 Sep; 46(3):187-92. PubMed ID: 8879854
[TBL] [Abstract][Full Text] [Related]
6. Hyperkalemic renal tubular acidosis induced by trimethoprim/sulfamethoxazole in an AIDS patient.
Sheehan MT; Wen SF
Clin Nephrol; 1998 Sep; 50(3):188-93. PubMed ID: 9776424
[TBL] [Abstract][Full Text] [Related]
7. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
Alappan R; Perazella MA; Buller GK
Ann Intern Med; 1996 Feb; 124(3):316-20. PubMed ID: 8554227
[TBL] [Abstract][Full Text] [Related]
8. Age-related changes in the hemostatic system.
Abbate R; Prisco D; Rostagno C; Boddi M; Gensini GF
Int J Clin Lab Res; 1993; 23(1):1-3. PubMed ID: 8477086
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism of trimethoprim-induced hyperkalemia.
Eiam-Ong S; Kurtzman NA; Sabatini S
Kidney Int; 1996 May; 49(5):1372-8. PubMed ID: 8731102
[TBL] [Abstract][Full Text] [Related]
10. Hyperkalemia and trimethoprim-sulfamethoxazole: a new problem emerges 25 years later.
Perazella MA
Conn Med; 1997 Aug; 61(8):451-8. PubMed ID: 9309892
[TBL] [Abstract][Full Text] [Related]
11. Reversal of trimethoprim-induced antikaliuresis.
Reiser IW; Chou SY; Brown MI; Porush JG
Kidney Int; 1996 Dec; 50(6):2063-9. PubMed ID: 8943491
[TBL] [Abstract][Full Text] [Related]
12. Impact of thrice-weekly cotrimoxazole prophylaxis on creatinine and potassium plasma levels in kidney transplant recipients.
Ardhe A; Devresse A; Crott R; De Meyer M; Mourad M; Goffin E; Kanaan N; Jadoul M
J Nephrol; 2023 Dec; 36(9):2581-2586. PubMed ID: 37715935
[TBL] [Abstract][Full Text] [Related]
13. Cotrimoxazole-induced hyperkalemia in renal transplant patient-Case report.
Srikaram P; Siddiqui A; Gul F; Deuja P; Fatima N
Clin Case Rep; 2022 Oct; 10(10):e6509. PubMed ID: 36285028
[TBL] [Abstract][Full Text] [Related]
14. Hypertension and human immunodeficiency virus: A paradigm for epithelial sodium channels?
Mutengo KH; Masenga SK; Mwesigwa N; Patel KP; Kirabo A
Front Cardiovasc Med; 2022; 9():968184. PubMed ID: 36093171
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic insights into the primary and secondary alterations of renal ion and water transport in the distal nephron.
Tabibzadeh N; Crambert G
J Intern Med; 2023 Jan; 293(1):4-22. PubMed ID: 35909256
[TBL] [Abstract][Full Text] [Related]
16. An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers.
Mohamed Pakkir Maideen N; Balasubramanian R; Muthusamy S; Nallasamy V
Curr Cardiol Rev; 2022; 18(6):e110522204611. PubMed ID: 35546745
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients.
Rizk JG; Lazo JG; Quan D; Gabardi S; Rizk Y; Streja E; Kovesdy CP; Kalantar-Zadeh K
Rev Endocr Metab Disord; 2021 Dec; 22(4):1157-1170. PubMed ID: 34292479
[TBL] [Abstract][Full Text] [Related]
18. Cotrimoxazole-induced hyperkalaemia in a patient with known hypoaldosteronism.
Montebello A; Gruppetta M
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33664032
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
